INS and Insulin resistance: Steiner et al. (2017) reported significantly elevated insulin resistance and fasting insulin levels in first-episode schizophrenia patients, accompanied by increased cortisol and catecholamine metabolites, suggesting a stress-related contribution to metabolic dysfunction​.